The US biocides market is experiencing steady growth driven by advancements in healthcare, water treatment, and stringent regulatory standards. The market is expected to reach USD 8,750 Million in 2035 from USD 5,100 Million in 2025, expanding at a CAGR of 5.3% from 2024 to 2035.
The economic impact of tariffs on "US Biocides Market".
Market Growth Drivers
Increasing demand for safe and clean water is a key driver of the US biocides market. The implementation of EPA and CDC guidelines regarding water purity has compelled water treatment facilities to incorporate advanced biocide solutions. Ecolab Inc., for example, has recently introduced innovative biocidal products specifically designed for municipal and industrial water treatment, expanding their market footprint and ensuring compliance with evolving regulations.
Rise in healthcare-associated infections (HAIs) has stimulated the adoption of biocides in the healthcare sector. Companies such as BASF Corporation have collaborated with leading hospital networks to deliver effective antimicrobial solutions, promoting better disinfection protocols and reducing infection rates in critical environments.
Market Trends
The growth of eco-friendly and non-toxic biocidal products is transforming the US market. Diversey, for instance, has developed an entire portfolio of green biocidal products leveraging plant-based ingredients, aligning with both regulatory guidelines and the broader trend toward sustainability in industrial cleaning applications.
Digitalization and automation integration in biocide application are on the rise. Solenis has pioneered smart dosing systems that enable real-time monitoring and optimal application of biocides within water treatment and manufacturing plants. This trend ensures higher efficacy, minimized chemical waste, and reduced operational costs.
Market Opportunities
Expansion in industrial applications such as oil & gas and manufacturing provides opportunities for tailored biocidal solutions. Lonza Group has started offering customized formulations to address industry-specific challenges, aiding companies to manage microbial contamination and ensure product quality.
Increased R&D investments in biotechnology-based biocides open vast growth avenues. Stepan Company is focusing on the development of biocidal agents derived from renewable resources, which are expected to gain rapid regulatory approval and market traction.
US Biocides Market Revenue (USD Million), 2020-2035
The US biocides market has witnessed steady revenue growth from 2020 to 2035, scaling from USD 3,900 Million in 2020 to a projected USD 8,750 Million in 2035. This upswing is attributed to the persistent demand in end-user industries, coupled with increased regulatory requirements for safety and hygiene. Key jumps in revenue are observed post-2024, paralleling technological advancements, industry expansions, and stronger safety mandates in water treatment, food processing, and healthcare sectors.
US Biocides Market Share by Region, 2025
In 2025, the regional market share for US biocides illustrates significant dominance by the South and Midwest regions, driven by large-scale industrial and agricultural activities. The South leads with 32% market share, followed by the Midwest at 27%. The West, Northeast, and Southeast account for 18%, 13%, and 10% respectively, reflecting differences in industry concentration, water treatment infrastructure, and regulatory focus across these areas.
Recent Developments (Past 6 Months)
In January 2024, Ecolab Inc. launched a next-generation biocide solution specifically tailored for food and beverage processing plants. This new offering guarantees enhanced protection against Listeria and Salmonella, supporting the rising demand for food safety compliance. The product leverages a unique blend of biodegradable surfactants, capturing significant market interest from large-scale processors.
In March 2024, Solenis expanded its North American production facilities to include a dedicated biocide blending line. This development aims to ensure robust supply chain support amidst rising industrial demand, and also allows faster delivery of customized solutions to clients in water treatment and pulp & paper sectors.
In May 2024, BASF Corporation entered into a strategic partnership with a leading US hospital network to trial an advanced antimicrobial biocide blend for surface disinfection. Preliminary data from the partnership indicates a 21% reduction in HAIs, which is anticipated to boost commercial adoption of the formulation once fully launched nationwide.
Press Releases